Search Within

Katherine S Panageas

Formats
  1. Journal Article (313)
  2. Meeting Abstract (177)
  3. Editorial (5)
  4. Research Letter (5)
  5. Correspondence (4)
  6. Review (4)
  7. Book Section (3)
  8. Miscellaneous (1)
Groups
  1. Biostatistics Service (512)
  2. Epidemiology and Biostatistics (512)
  3. Population Sciences Research Program (512)
  4. Department of Medicine (298)
  5. Solid Tumor Oncology Division (256)
  6. GSK Faculty (186)

More Groups

People
  1. Jedd Wolchok (92)
  2. Anne Reiner (90)
  3. Lisa De Angelis (85)
  4. Paul Chapman (77)
  5. Michael Postow (64)
  6. Clifford Hudis (56)

More People

Years
  1. 2025 (8)
  2. 2024 (23)
  3. 2023 (28)
  4. 2022 (28)
  5. 2021 (34)
  6. 2020 (29)

More Years

Publications
  1. Journal of Clinical Oncology (105)
  2. Neuro-Oncology (40)
  3. Clinical Cancer Research (31)
  4. Annals of Surgical Oncology (28)
  5. Cancer (21)
  6. Breast Cancer Research and Treatment (20)

More Publications

Publishers
  1. American Society of Clinical Oncology (118)
  2. Oxford University Press (65)
  3. Springer (65)
  4. American Association for Cancer Research (56)
  5. Wiley Blackwell (38)
  6. American Medical Association (19)

More Publishers

Results (512)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Appropriate statistical methods are available to handle biases encountered in blinded, independent, central review (BICR) determined progression-free survival
    Editorial

    Lavery, J. A.; Panageas, K. S.
    Journal of Hospital Management and Health Policy (2019)

    Fulltext@MSK | Save
  • Increased number of high dose methotrexate cycles and the addition of rituximab is associated with better outcomes in a large primary CNSL cohort
    Meeting Abstract

    Yerram, P.; Reiss, S. N.; Modelevsky, L.; Schaff, L.; Reiner, A.; Panageas, K.; Grommes, C.
    Blood (2019)

    Fulltext@MSK | Save
  • Rosai-Dorfman-Destombes disease of the nervous system; A systematic literature review
    Meeting Abstract

    Alshiekh Nasany, R.; Reiner, A.; Panageas, K.; Diamond, E.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • EEG features that independently associate with higher grade neurotoxicity in patients treated with chimeric antigen receptor (CAR) T cell therapy
    Meeting Abstract

    Mao, D.; Kotchetkov, I.; Reiner, A.; Panageas, K.; Chen, X.; Avila, E.; Santomasso, B.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Patient and physician perspectives on lumbar puncture
    Meeting Abstract

    Umemura, Y.; Weill, B.; Khan, B.; Buthorn, J.; Ridder, A.; Nevel, K.; Panageas, K.; Boire, A.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Selective inhibition of low-affinity memory CD8(+) T cells by corticosteroids
    Journal Article

    Tokunaga, A.; Sugiyama, D.; Maeda, Y.; Warner, A. B.; Panageas, K. S.; Ito, S.; Togashi, Y.; Sakai, C.; Wolchok, J. D.; Nishikawa, H.
    Journal of Experimental Medicine (2019)

    Fulltext@MSK | Save
  • Responders to anti-PD1 therapy: Long-term outcomes and responses to retreatment in melanoma (mel)
    Meeting Abstract

    Warner, A. B.; Palmer, J. S.; Shoushtari, A. N.; Goldman, D. A.; Panageas, K.; Callahan, M. K.; Wolchok, J. D.; Postow, M. A.; Chapman, P. B.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A new model of care for patients with central nervous system cancers
    Meeting Abstract

    Nevel, K. S.; Konig, F.; Skakodub, A.; Davis, M. E.; Sibilla, M.; Harrison, M.; Rawlins-Peters, G.; Jean-Charles, D.; Zankowsky, A.; Gilman, J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Opportunity for performance measurement: 30-day mortality following cancer surgeries across US hospitals
    Meeting Abstract

    Lipitz-Snyderman, A.; Lavery, J. A.; Bach, P.; Li, D. G.; Yang, A.; Strong, V. E.; Russo, A.; Panageas, K.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Durable clinical benefit from combination ipilimumab (IPI) and nivolumab (NIVO) in anti-PD-1 therapy resistant, platinum resistant metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Keegan, N. M.; Funt, S. A.; Kania, B. E.; Iyer, G.; Clement, J. M.; McCoy, A. S.; Hettich, G.; Ziv, E.; Maher, C. A.; Nair, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save